Development of a mHealth Intervention for Ambivalent Smokers

January 3, 2023 updated by: Kaiser Permanente
The current pilot study will assess the feasibility and acceptability of a novel mHealth app designed for people who are ambivalent about quitting smoking. Results will be used to refine the intervention and plan for a future randomized effectiveness trial.

Study Overview

Study Type

Interventional

Enrollment (Actual)

57

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Washington
      • Seattle, Washington, United States, 98101
        • Kaiser Permanente Washington Health Research Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18 years or older;
  • Can speak/read English;
  • Current smoker;
  • Own and regularly use an eligible smartphone;
  • No vision impairments;
  • Willing to install and use the study program;
  • Willing to use birth control if elect to use nicotine replacement during the study (females);
  • Meet definition for ambivalence
  • Not actively using treatment

Exclusion Criteria:

  • Smoke less than 10 cigarettes per day
  • Self-report a lifetime history of dementia, manic depression, bipolar disorder, or schizophrenia;
  • Have medical contraindications for nicotine replacement therapy;
  • Another household member is enrolled in the study
  • Unable to verify contact information
  • Fail to install app

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Device Feasibility
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental
Participants in both arms can earn the ability to request a 2-week supply of over-the-counter nicotine patches. Patches are earned through accumulated use of the assigned mHealth program.
The intervention includes a mHealth intervention that is grounded in best practice recommendations for treatment of nicotine dependence. Experimental participants also receive additional content designed to motivate smoking reduction/quitting and provide skills training.
Active Comparator: Control
The intervention includes a mHealth intervention that is grounded in best practice recommendations for treatment of nicotine dependence.
Participants in both arms can earn the ability to request a 2-week supply of over-the-counter nicotine patches. Patches are earned through accumulated use of the assigned mHealth program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Program Engagement
Time Frame: Assessed at 3-month follow-up
Number of unique app user-sessions
Assessed at 3-month follow-up
Quit Attempt Lasting at Least 24 Hours
Time Frame: Assessed at 3-month follow-up
At least one intentional smoking quit attempt lasting at least 24 hours. Missing outcomes imputed as not making a quit attempt.
Assessed at 3-month follow-up
Not Smoking (Even a Puff) in the Last 7 Days
Time Frame: Assessed at 3-month follow-up
7-day point prevalent abstinence: self-report of not smoking, even a puff, in the last 7 days. Missing values were imputed as smoking.
Assessed at 3-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction With Assigned App
Time Frame: Assessed at 1 month
Satisfaction with the overall "content and advice" of the assigned app, rated on a Likert scale from 1="not at all satisfied" to 5="extremely satisfied".
Assessed at 1 month
Satisfaction With Assigned App
Time Frame: Assessed at 3 months
Satisfaction with the overall "content and advice" of the assigned app on a Likert scale from 1="not at all satisfied" to 5="extremely satisfied".
Assessed at 3 months
Helpfulness of Assigned App
Time Frame: Assessed at 1 month.
Global helpfulness rating calculated as the average helpfulness rating of 8 app features, each rated on a Likert scale from 1="not at all helpful" to 5="extremely helpful".
Assessed at 1 month.
Helpfulness of Assigned App
Time Frame: Assessed at 3 months
Average helpfulness rating of 8 separate app features, with each feature rated on a Likert scale from 1="not at all helpful" to 5="extremely helpful".
Assessed at 3 months
Program Engagement - Earned Badges
Time Frame: Assessed at 1-month follow-up
Number of accumulated badge rewards earned from using the assigned app.
Assessed at 1-month follow-up
Program Engagement - Earned Badges
Time Frame: Assessed at 3-month follow-up
Number of accumulated badge rewards earned from using the assigned app.
Assessed at 3-month follow-up
Self-efficacy to Quit Smoking
Time Frame: Assessed at 1 month
Self-reported confidence in quitting smoking on Likert scale from 1="not at all" to 10="extremely".
Assessed at 1 month
Self-efficacy to Quit Smoking
Time Frame: Assessed at 3 months
Self-reported confidence in quitting smoking on a Likert scale from 1="not at all" to 10="extremely".
Assessed at 3 months
Self-efficacy to Stay Quit
Time Frame: Assessed at 1 month
Self-reported confidence in ability to stay quit on a Likert scale from 1="not at all" to 10="extremely".
Assessed at 1 month
Self-efficacy to Stay Quit
Time Frame: Assessed at 3 months
Self-reported confidence in ability to stay quit (if no smoking in the past 7 days) on a Likert scale from 1="not at all" to 10="extremely".
Assessed at 3 months
Earned and Requested Free Nicotine Replacement Therapy
Time Frame: Assessed at 1-month follow-up
Earned and requested free nicotine replacement therapy (NRT); free NRT could be earned by earning 6 app utilization badges.
Assessed at 1-month follow-up
Earned and Requested Free Nicotine Replacement Therapy
Time Frame: Assessed at 3-month follow-up
Earned and requested free nicotine replacement therapy (NRT); free NRT could be earned by earning 6 app utilization badges.
Assessed at 3-month follow-up
Quit Attempt Lasting at Least 24 Hours
Time Frame: Assessed at 1 month follow-up
At least one intentional smoking quit attempt lasting at least 24 hours; non-respondents were assumed to not have a successful quit attempt.
Assessed at 1 month follow-up
Change in Cigarettes/Day
Time Frame: Assessed at baseline and 1 month
Change in number of cigarettes smoked per day from baseline, calculated as (1 month)-baseline.
Assessed at baseline and 1 month
Change in Cigarettes/Day
Time Frame: Assessed at baseline and 3 months
Change in number of cigarettes smoked per day from baseline, calculated as (3 months)-baseline.
Assessed at baseline and 3 months
Refrain From Smoking (Even a Puff) in the Last 7 Days
Time Frame: Assessed at 1-month follow-up
7-day point prevalent abstinence: a self-report of not smoking, even a puff, in the past 7 days. Missing outcomes were imputed as smoking.
Assessed at 1-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jennifer McClure, PhD, Kaiser Permanente

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 16, 2020

Primary Completion (Actual)

September 27, 2021

Study Completion (Actual)

September 27, 2021

Study Registration Dates

First Submitted

June 15, 2020

First Submitted That Met QC Criteria

September 17, 2020

First Posted (Actual)

September 23, 2020

Study Record Updates

Last Update Posted (Actual)

January 23, 2023

Last Update Submitted That Met QC Criteria

January 3, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

Data will not be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on Control mHealth program

3
Subscribe